Dow Extends Yesterday's Rally With Triple-Digit Pop Midday

Many on Wall Street, however, don't believe the rally can last

Deputy Editor
Mar 25, 2020 at 12:41 PM
facebook twitter linkedin

Falling back earlier following this morning's modest rally, the Dow Jones Industrial Average (DJI) is now seeing a resurgence, up over 800 points midday thanks to boosts from Boeing (BA) and Nike (NKE), the latter surging on an earnings beat. The S&P 500 Index (SPX) and Nasdaq Composite (IXIC) are also notably higher at the halfway point. 

This surge in stocks comes on the heels of the $2 trillion emergency stimulus bill just passed by Congress late last night. Not everyone on Wall Street believes stocks have hit rock bottom just yet, though. Director of U.S. institutional equities at INTL FCStone Yousef Abbasi commented that due to uncertainty in the workforce seeing "a sustainable rally at this point, is going to be very difficult." 

Continue reading for more on today's market, including: 

  • Hershey stock looks sweet after a double upgrade.  
  • The FAANG name SunTrust Robinson is eyeing in the long-term. 
  • Plus, Cannae calls pop; the burger joint moving out of its slump; and the biotech name faltering.

NEW new midday market stats mar 25

One stock sporting unusual options volume today is Cannae Holdings Inc (NYSE:CNNE), last seen up 2.3% to trade at $33.76. So far the restaurant investor has had 3,585 calls and 502 puts cross the tape -- eight times the typical daily volume. Most popular are the May 30 and May 35 calls, with positions being opened at the latter.

One of the best performers on the Nasdaq today is Red Robin Gourmet Burgers, Inc. (NASDAQ:RRGB), up 24.4% to trade at $12.77 at last check. While the reason for the surge isn't clear, the restaurant company has been steadily moving up from its March 18 record low, and recently broke back above the former resistance at its 10-day moving average. 

Meanwhile, near the bottom of the Nasdaq is Allakos Inc (NASDAQ:ALLK), down 13.9% to trade at $50.85 so far today. This dip comes after the biotech concern announced the initiation clinical studies for its antolimab (AK002) treatment, used to treat eosinophil mast cell related diseases. On the charts, pressure at its 20-day moving average has been guiding ALLK lower during the past few months. For the year, the equity is off 45.3%. 

mmc chart Mar 25


Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 



Special Offers from Schaeffer's Trading Partners